Sunil Agarwal
Equibles does not estimate personal net worth.
About Sunil Agarwal
Sana Biotechnology, Inc. reported in an 8-K filed April 10, 2023 that Sunil Agarwal resigned as Executive Vice President, Head of Development, and Chief Medical Officer, effective April 10, 2023. The proxy statement of Sana Biotechnology, Inc. reports total compensation of $1,659,608 for Sunil Agarwal in fiscal 2022, including a base salary of $530,863. Disclosed compensation is on record for 2 fiscal years.
“The Company also announced that, Sunil Agarwal, M.D. resigned from his position as Executive Vice President, Head of Development, and Chief Medical Officer of the Company, effective as of April 10, 2023.”
Affiliation history
-
Sana Biotechnology, Inc. (SANA)
Proxy statement
Start not stated–2023-04-10
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Sana Biotechnology, Inc. (SANA) | Former Executive Vice President, Head of Development, and Chief Medical Officer | $530,863 | $1,659,608 |
| 2021 | Sana Biotechnology, Inc. (SANA) | Former Executive Vice President, Head of Development, and Chief Medical Officer | $512,631 | $1,928,519 |